Donald Trump's renewed push to take control of Greenland is setting off a high-stakes showdown with Denmark, a small country ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

Find insight on AstraZeneca, Eli Lilly, Siemens Healthineers and more in the latest Market Talks covering Health Care.

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Trump's tax plans mean good times for junkyards. Plus, Disney makes dollars, Google changes its tune, and Bitcoin takes a hit ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.